Exane Derivatives’s WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT WPZ Stock Holding History
Bought
Maintained
Sold
Other funds holding WPZ
TCA
EIP
TT
SCM
SIC
CVSCT
V
CPIG
CCM
Exane Derivatives's WPZ Position: Q1 2015 in Review
Exane Derivatives sold out of WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT (WPZ) in Q1 2015, closing a stake of 324 shares — an estimated $13.6K sold.
Exane Derivatives first reported a position in WPZ in Q4 2014 and held it in 1 quarter. The position peaked at $13.6K in Q4 2014. 43 funds tracked by Wall St. Rank hold WPZ as of Q1 2015.
- Exane Derivatives reported no remaining WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT position as of Q1 2015 after selling out during the quarter.
- Exane Derivatives sold 324 WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT shares in Q1 2015, an estimated $13.6K.
- Exane Derivatives first reported a position in WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT in Q4 2014 and held it in 1 quarter.
- Exane Derivatives's WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT position peaked at $13.6K in Q4 2014.
- 43 funds tracked by Wall St. Rank held WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT as of Q1 2015.
Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.